Avalyn Pharma, Inc. (AVLN)
37.39
+1.95
(+5.50%)
USD |
NASDAQ |
Sep 04, 16:00
37.00
-0.39
(-1.04%)
After-Hours: 20:00
Avalyn Pharma EPS Diluted (Quarterly) : -0.6527 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6527 |
| March 31, 2026 | -0.6061 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.4554 |
| March 31, 2025 | -0.3948 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -0.1781 |
| CorMedix, Inc. | 0.281 |
| Eloxx Pharmaceuticals, Inc. | -0.6631 |
| Cannabis Global, Inc. | 0.00 |
| Breakthrough Chemistry, Inc. | -0.1113 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -28.94M |
| Total Expenses (Quarterly) | 28.94M |
| Enterprise Value | 1.322B |
| Earnings Yield | -5.64% |
| Normalized Earnings Yield | -5.640 |